HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koch, S. Articles by Beisiegel, U. Search for Related Content PubMed PubMed Citation Articles by Koch, S. Articles by Beisiegel, U. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 42, 1143-1151, July 2001
Copyright © 2001 by Lipid Research, Inc.

Original Article

Characterization of four lipoprotein classes in human cerebrospinal fluid

Correspondence to: Ulrike Beisiegel, To whom correspondence should be addressed., beisiegel{at}uke.uni-hamburg.de (E-mail)

Lipoprotein metabolism in brain has not yet been fully elucidated, although there are a few reports concerning lipids in the brain and lipoproteins and apolipoproteins in the cerebrospinal fluid (CSF). To establish normal levels of lipoproteins in human CSF, total cholesterol, phospholipids, and fatty acids as well as apolipoprotein E (apoE) and apoA-I levels were determined in CSF samples from 216 individuals. For particle characterization, lipoproteins from human CSF were isolated by affinity chromatography and analyzed for size, lipid and apolipoprotein composition. Two consecutive immunoaffinity columns with antibodies, first against apoE and subsequently against apoA-I, were used to define four distinct lipoprotein classes. The major lipoprotein fraction consisted of particles of 13;–20 nm containing apoE and apoA-I as well as apoA-IV, apoD, apoH, and apoJ. In the second particle class (13;–18 nm) mainly apoA-I and apoA-II but no apoE was detected. Third, there was a small number of large particles (18;–22 nm) containing no apoA-I but apoE associated with apoA-IV, apoD, and apoJ. In the unbound fraction we detected small particles (10;–12 nm) with low lipid content containing apoA-IV, apoD, apoH, and apoJ.

In summary, we established lipid and apolipoprotein levels in CSF in a large group of individuals and described four distinct lipoprotein classes in human CSF, differing in their apolipoprotein pattern, lipid composition, and size. On the basis of our own data and previous findings from other groups, we propose a classification of CSF lipoproteins. — Koch, S., N. Donarski, K. Goetze, M. Kreckel, H-J. Stuerenburg, C. Buhmann, and U. Beisiegel. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 2001. 42: 1143;–1151.

Supplementary key words: affinity chromatography, apolipoprotein E, apolipoprotein A-I, cholesterol, phospholipids

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. R. Bales, F. Liu, S. Wu, S. Lin, D. Koger, C. DeLong, J. C. Hansen, P. M. Sullivan, and S. M. Paul Human APOE Isoform-Dependent Effects on Brain {beta}-Amyloid Levels in PDAPP Transgenic Mice J. Neurosci., May 27, 2009; 29(21): 6771 - 6779. [Abstract] [Full Text] [PDF]

				V. Hirsch-Reinshagen, J. Donkin, S. Stukas, J. Chan, A. Wilkinson, J. Fan, J. S. Parks, J. A. Kuivenhoven, D. Lutjohann, H. Pritchard, et al. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins J. Lipid Res., May 1, 2009; 50(5): 885 - 893. [Abstract] [Full Text] [PDF]

				X. Xian, T. Liu, J. Yu, Y. Wang, Y. Miao, J. Zhang, Y. Yu, C. Ross, J. M. Karasinska, M. R. Hayden, et al. Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice J. Neurosci., April 8, 2009; 29(14): 4681 - 4685. [Abstract] [Full Text] [PDF]

				A. E. Pasvogel, P. Miketova, and I. M. Moore Cerebrospinal Fluid Phospholipid Changes Following Traumatic Brain Injury Biol Res Nurs, October 1, 2008; 10(2): 113 - 120. [Abstract] [PDF]

				A. Kontush and M. J. Chapman HDL: Close to Our Memories? Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1418 - 1420. [Full Text] [PDF]

				R. Simo, M. Higuera, M. Garcia-Ramirez, F. Canals, J. Garcia-Arumi, and C. Hernandez Elevation of Apolipoprotein A-I and Apolipoprotein H Levels in the Vitreous Fluid and Overexpression in the Retina of Diabetic Patients Arch Ophthalmol, August 1, 2008; 126(8): 1076 - 1081. [Abstract] [Full Text] [PDF]

				A. Lyly, S. K. Marjavaara, A. Kyttala, K. Uusi-Rauva, K. Luiro, O. Kopra, L. O. Martinez, K. Tanhuanpaa, N. Kalkkinen, A. Suomalainen, et al. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism Hum. Mol. Genet., May 15, 2008; 17(10): 1406 - 1417. [Abstract] [Full Text] [PDF]

				Y. Nagayasu, J.-i. Ito, T. Nishida, and S. Yokoyama Reactivity of Astrocytes to Fibroblast Growth Factor-1 for Biogenesis of Apolipoprotein E-High Density Lipoprotein is Down-regulated by Long-time Secondary Culture J. Biochem., May 1, 2008; 143(5): 611 - 616. [Abstract] [Full Text] [PDF]

				J.-i. Ito, Y. Nagayasu, K. Okumura-Noji, R. Lu, T. Nishida, Y. Miura, K. Asai, A. Kheirollah, S. Nakaya, and S. Yokoyama Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes J. Lipid Res., September 1, 2007; 48(9): 2020 - 2027. [Abstract] [Full Text] [PDF]

				W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861. [Abstract] [Full Text] [PDF]

				G. Pepe, G. Chimienti, G. M. Liuzzi, B. L. Lamanuzzi, M. Nardulli, F. Lolli, E. Angles-Cano, and S. Mata Lipoprotein(a) in the Cerebrospinal Fluid of Neurological Patients with Blood-Cerebrospinal Fluid Barrier Dysfunction Clin. Chem., November 1, 2006; 52(11): 2043 - 2048. [Abstract] [Full Text] [PDF]

				B. Karten, R. B. Campenot, D. E. Vance, and J. E. Vance Expression of ABCG1, but Not ABCA1, Correlates with Cholesterol Release by Cerebellar Astroglia J. Biol. Chem., February 17, 2006; 281(7): 4049 - 4057. [Abstract] [Full Text] [PDF]

				V. Hirsch-Reinshagen, L. F. Maia, B. L. Burgess, J.-F. Blain, K. E. Naus, S. A. McIsaac, P. F. Parkinson, J. Y. Chan, G. H. Tansley, M. R. Hayden, et al. The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease J. Biol. Chem., December 30, 2005; 280(52): 43243 - 43256. [Abstract] [Full Text] [PDF]

				G Ferretti, T Bacchetti, F Principi, F Di Ludovico, B Viti, V A Angeleri, M Danni, and L Provinciali Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity Multiple Sclerosis, December 1, 2005; 11(6): 677 - 682. [Abstract] [PDF]

				J.-i. Ito, Y. Nagayasu, R. Lu, A. Kheirollah, M. Hayashi, and S. Yokoyama Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action J. Lipid Res., April 1, 2005; 46(4): 679 - 686. [Abstract] [Full Text] [PDF]

				C.-M. Li, J. B. Presley, X. Zhang, N. Dashti, B. H. Chung, N. E. Medeiros, C. Guidry, and C. A. Curcio Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy J. Lipid Res., April 1, 2005; 46(4): 628 - 640. [Abstract] [Full Text] [PDF]

				J.-i. Ito, H. Li, Y. Nagayasu, A. Kheirollah, and S. Yokoyama Apolipoprotein A-I induces translocation of protein kinase C{alpha} to a cytosolic lipid-protein particle in astrocytes J. Lipid Res., December 1, 2004; 45(12): 2269 - 2276. [Abstract] [Full Text] [PDF]

				N. J. Bray, L. Jehu, V. Moskvina, J. D. Buxbaum, S. Dracheva, V. Haroutunian, J. Williams, P. R. Buckland, M. J. Owen, and M. C. O'Donovan Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes Hum. Mol. Genet., November 15, 2004; 13(22): 2885 - 2892. [Abstract] [Full Text] [PDF]

				K. M. Mann, F. E. Thorngate, Y. Katoh-Fukui, H. Hamanaka, D. L. Williams, S. Fujita, and B. T. Lamb Independent effects of APOE on cholesterol metabolism and brain A{beta} levels in an Alzheimer disease mouse model Hum. Mol. Genet., September 1, 2004; 13(17): 1959 - 1968. [Abstract] [Full Text] [PDF]

				N. Wang, D. Lan, W. Chen, F. Matsuura, and A. R. Tall ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins PNAS, June 29, 2004; 101(26): 9774 - 9779. [Abstract] [Full Text] [PDF]

				G. T. Vatassery, Adityanjee, H. T. Quach, W. E. Smith, M. A. Kuskowski, and D. Melnyk Alpha and Gamma Tocopherols in Cerebrospinal Fluid and Serum from Older, Male, Human Subjects J. Am. Coll. Nutr., June 1, 2004; 23(3): 233 - 238. [Abstract] [Full Text] [PDF]

				H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures J. Biol. Chem., April 2, 2004; 279(14): 14009 - 14015. [Abstract] [Full Text] [PDF]

				R. M. DeKroon, M. Mihovilovic, Z. V. Goodger, J. B. Robinette, P. M. Sullivan, A. M. Saunders, and W. J. Strittmatter ApoE genotype-specific inhibition of apoptosis J. Lipid Res., August 1, 2003; 44(8): 1566 - 1573. [Abstract] [Full Text] [PDF]

				A. Rigotti, H. E. Miettinen, and M. Krieger The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues Endocr. Rev., June 1, 2003; 24(3): 357 - 387. [Abstract] [Full Text] [PDF]

				E. Paradis, S. Clement, P. Julien, and M. R. Ven Murthy Lipoprotein Lipase Affects the Survival and Differentiation of Neural Cells Exposed to Very Low Density Lipoprotein J. Biol. Chem., March 7, 2003; 278(11): 9698 - 9705. [Abstract] [Full Text] [PDF]

				B. Karten, D. E. Vance, R. B. Campenot, and J. E. Vance Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons J. Biol. Chem., January 31, 2003; 278(6): 4168 - 4175. [Abstract] [Full Text] [PDF]

				H. Fukumoto, A. Deng, M. C. Irizarry, M. L. Fitzgerald, and G. W. Rebeck Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Abeta Levels J. Biol. Chem., December 6, 2002; 277(50): 48508 - 48513. [Abstract] [Full Text] [PDF]

				T. Suzuki, M. Tozuka, K. Yamauchi, M. Sugano, T. Nakabayashi, N. Okumura, H. Hidaka, T. Katsuyama, and K. Higuchi Predominant Apolipoprotein J Exists as Lipid-poor Mixtures in Cerebrospinal Fluid Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 369 - 376. [Abstract] [Full Text] [PDF]

				R. Gander, P. Eller, S. Kaser, I. Theurl, D. Walter, T. Sauper, A. Ritsch, J. R. Patsch, and B. Foger Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein J. Lipid Res., April 1, 2002; 43(4): 636 - 645. [Abstract] [Full Text] [PDF]